Monograph

J01CA01 - Ampicillin

Not porphyrinogenic

Rationale

Clinical experience as well as several references indicate non-porphyrinogenicity.

Chemical description

Penicillin derivative broadspectrum antibiotic for parenteral use. Metabolized to slight extent to penicilloic acid but 79-92 % of the dose is excreted unchanged. South African list: use. Australian list: safe. Thunell: repeatedly shown to be safe.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes J01C / J01CA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

United Kingdom

Ampicillin · Ampicillin 125mg/5ml oral suspension · Ampicillin 250mg capsules · Ampicillin 250mg/5ml oral suspension · Ampicillin 500mg capsules · Ampicillin 500mg powder for solution for injection vials · Penbritin · Penbritin 125mg/5ml syrup · Penbritin 250mg capsules · Penbritin 500mg capsules · Penbritin 500mg powder for solution for injection vials · Penbritin Forte · Penbritin Forte 250mg/5ml syrup

Denmark